Literature DB >> 16157754

Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.

Paul J Tuite1, H Brent Clark, Catherine Bergeron, Matthew Bower, Peter St George-Hyslop, Vesselina Mateva, John Anderson, David S Knopman.   

Abstract

BACKGROUND: Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are neurodegenerative tauopathies. Sporadic and familial cases of PSP and CBD have been noted, but both have not been reported in a single family.
OBJECTIVE: To describe the clinical, oculomotor, balance, functional imaging, histopathologic, and genetic studies in a family with CBD and PSP.
DESIGN: A report of the clinical and pathological features in a familial tauopathy.
SETTING: University of Minnesota. Patients We evaluated 2 siblings and clinically assessed 20 additional family members. MAIN OUTCOME MEASURES: Demonstration of salient features in deceased and living family members.
RESULTS: Histopathologically confirmed CBD in one sibling and PSP in another deceased sibling were demonstrated; both had clinical features of corticobasal syndrome. In addition, 3 siblings had probable PSP by clinical criteria. Genetic studies of 4 affected family members demonstrated the H1/H1 haplotype but did not reveal pathogenic tau mutations. The family history revealed consanguinity.
CONCLUSIONS: This is the first report, to our knowledge, of CBD and PSP in 2 individuals in a single family who presented with corticobasal syndrome and had other affected siblings with clinical PSP. Despite clinical and pathologic heterogeneity, a unifying genetic etiology appears likely in this familial tauopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157754     DOI: 10.1001/archneur.62.9.1453

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study.

Authors:  Shinsuke Fujioka; Bradley F Boeve; Joseph E Parisi; Pawel Tacik; Naoya Aoki; Audrey J Strongosky; Matt Baker; Monica Sanchez-Contreras; Owen A Ross; Rosa Rademakers; Vesna Sossi; Dennis W Dickson; A Jon Stoessl; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2014-08-19       Impact factor: 4.891

2.  Phenotypic variation of autosomal-dominant corticobasal degeneration.

Authors:  Hans H Jung; Juliane Bremer; Johannes Streffer; Kanwar Virdee; Maria Grazia Spillantini; R Anthony Crowther; Peter Brugger; Christine Van Broeckhoven; Adriano Aguzzi; Markus Tolnay
Journal:  Eur Neurol       Date:  2012-01-18       Impact factor: 1.710

Review 3.  Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders.

Authors:  Sonja W Scholz; Jose Bras
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

4.  Early-onset dementias: diagnostic and etiological considerations.

Authors:  Mario Masellis; Kayla Sherborn; Pedro Neto; Dessa A Sadovnick; Ging-Yuek R Hsiung; Sandra E Black; Sadhana Prasad; Meghan Williams; Serge Gauthier
Journal:  Alzheimers Res Ther       Date:  2013-07-31       Impact factor: 6.982

5.  Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Authors:  Shelley L Forrest; Jillian J Kril; Claire H Stevens; John B Kwok; Marianne Hallupp; Woojin S Kim; Yue Huang; Ciara V McGinley; Hellen Werka; Matthew C Kiernan; Jürgen Götz; Maria Grazia Spillantini; John R Hodges; Lars M Ittner; Glenda M Halliday
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

6.  Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer.

Authors:  Helen Ling; Eleanna Kara; Tamas Revesz; Andrew J Lees; Gordon T Plant; Davide Martino; Henry Houlden; John Hardy; Janice L Holton
Journal:  Acta Neuropathol Commun       Date:  2014-02-21       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.